{
  "paper_metadata": {
    "pmid": "39077339",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "3.5% of African Americans, especially of Western African origin",
        "phenotype": "ATTRv-CA"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "70-80 years",
            "penetrance_percentage": 60.0,
            "carriers_in_range": 3,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": 62,
          "age_at_diagnosis": 64,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "heart failure with preserved ejection fraction",
          "evidence_sentence": "The patient was diagnosed with heart failure at age 64."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis with significant symptoms",
          "evidence_sentence": "This individual presented with significant symptoms of cardiac amyloidosis."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 72,
          "age_at_onset": 70,
          "age_at_diagnosis": 71,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms observed",
          "evidence_sentence": "Despite being a carrier, this individual has shown no symptoms."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile variant is associated with altered protein stability and amyloid fibril formation.",
        "assays": [
          "in vitro stability assays",
          "amyloid fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "3.5% in African Americans",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is the most common mutation causing ATTRv-CA in the USA.",
      "key_quotes": [
        "Valine-to-isoleucine substitution at position 122 (Val122Ile) is the most common mutation causing ATTRv-CA in the USA.",
        "The true prevalence of ATTR-CA in the population is unknown."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}